P-249 Resecting the unresectable: Superior survival of tri-modality pancreatic adenocarcinoma patients

The majority of patients with pancreatic adenocarcinoma are deemed unresectable on initial diagnosis due to locally advanced or metastatic disease. Their overall median survival is approximately 10 – 12 months. This is largely due to the dissemination of pancreatic tumour cells early prior to its formation via epithelial-to-mesenchymal transition. Recent publications showed the use of chemotherapy converting unresectable to resectable tumours,...